Plasma lipoproteins in patients with chronic renal failure (CRF)

International Urology and Nephrology

Volumn 29, Issue 5, 1997, Pages 597-601

  Kimak, E ^a   Solski, J ^a   Janicka, L ^b   Duma, D ^a   Zagojska, M ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Jan Bozy District Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; RISK FACTOR;

ADOLESCENT; ADULT; CHOLESTEROL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REFERENCE VALUES; RENAL DIALYSIS;

EID: 0030670926     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02552207     Document Type: Article

References (12)

1. Alaupovic, P., Attman, P. O.: Lipid and apolipoprotein profiles of uremic dyslipoproteinemia: Relation to renal function and dialysis. Nephron, 57, 401 (1991).
2. Aiyoath, L. O., Sirisolee, K., Shayakul, C.: Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients. Transplant. Proc., 26, 2077 (1994).
3. Appel, G.: Lipid abnormalities in renal disease. Kidney Int., 39, 169 (1991).
4. Attman, P. O.: Hyperlipoproteinemia in renal failure: Pathogenesis and perspectives for intervention. Nephrol. Dial. Transplant., 8, 294 (1993).
5. Blankestijn, P. J.: Hemodialysis using high flux membranes improves lipid profiles. Clin. Nephrol., 42, 48 (1994).
6. Brown, M. S., Goldstein, J. L., Kovanen, P. T.: Regulation of cholesterol by lipoprotein receptors. Science, 212, 628 (1981).
7. Dnistrian, A. M., Schwartz, M. K., Greenberg, E. J.: Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy. Clin. Chim. Acta, 223, 43 (1993).
8. Docci, D., Capponcini, C., Mengozzi, S.: Effects of different dialysis membranes on lipid and lipoprotein in hemodialysis patients. Nephron, 69, 323 (1995).
9. Heremans, J. F., Garbonara, A. D., Mancini, G.: Immunochemistry, 2, 235 (1965).
10. Ksia+ (Combining ogonek)żek, A., Marczewski, K., Sokołowska, G., Solski, J.: Leukopenia with different regenerated hemodialysis membranes. Int. Urol. Nephrol., 16, 61 (1984).
11. Parsy, D., Dracon, M., Cachera, C.: Lipoprotein abnormalities in chronic haemodialysis patients. Nephrol. Dial. Transplant., 3, 51 (1988).
12. Väisänen, S., Gävert, J., Julkunen, A.: Correlation between the ratio of serum low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with that of serum apolipoproteins B and A-I. Int. J. Clin. Lab. Res., 23, 160 (1993).